Literature DB >> 31081704

Screening, prenatal diagnosis, and prenatal decision for sex chromosome aneuploidy.

Yong Xu1, Liyuan Chen1, Yang Liu1, Ying Hao1, Zhiyong Xu1, Liyanyan Deng2, Jiansheng Xie1.   

Abstract

Objective: To assess the performance of non-invasive prenatal testing (NIPT) in screening sex chromosome aneuploidy (SCA), and explore prenatal decision-making in NIPT positive cases.
Methods: The study retrospectively analyses singleton pregnancies who underwent NIPT screening. Clinical data, diagnostic results, and pregnancy outcomes were also collected.
Results: There were 140 positive screens for SCA, including 62 cases of 45,X, 29 cases with 47,XXX, 28 cases of 47,XXY, 20 cases of 47,XYY, and one case of lower X chromosome. Karyotypic information was available in 103 cases. The positive predictive value was 26.09% for 45,X, 85.00% for 47,XXX, 85.00% for 47,XXY, and 68.75% for 47,XYY. The termination rates of 45,X, 47,XXX, 47,XXY, 47,XYY were 83.33%, 26.67%, 82.35%, and 54.54%, respectively (not including mosaic cases).
Conclusion: Our findings demonstrated that the NIPT performed better in predicting sex chromosome trisomies than monosomy X even though false-positive cases do exist in NIPT. For prenatal decisions, pregnancies with diagnoses of fetal 45,X and 47,XXY were terminated more often than those with 47,XXX, 47,XYY. To better guide positive screening pregnancies, pre- and post-test counseling are essential in telling patients the benefits and limitations of the test, comforting their anxiety and giving them the choice for further diagnosis and pregnancy decision.

Entities:  

Keywords:  Non-invasive prenatal testing (NIPT); positive predictive value (PPV); prenatal decision; prenatal diagnosis; sex chromosome aneuploidy (SCA)

Year:  2019        PMID: 31081704     DOI: 10.1080/14737159.2019.1613154

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  8 in total

1.  Positive predictive value estimates for noninvasive prenatal testing from data of a prenatal diagnosis laboratory and literature review.

Authors:  Siping Liu; Fang Yang; Qingxian Chang; Bei Jia; Yushuang Xu; Ruifeng Wu; Liyan Li; Weishan Chen; Ailan Yin; Fodi Huang; Suxin Feng; Fenxia Li
Journal:  Mol Cytogenet       Date:  2022-07-06       Impact factor: 1.904

Review 2.  Diagnostic cytogenetic testing following positive noninvasive prenatal screening results of sex chromosome abnormalities: Report of five cases and systematic review of evidence.

Authors:  Xiaolei Xie; Weihe Tan; Fuguang Li; Eric Carrano; Paola Ramirez; Autumn DiAdamo; Brittany Grommisch; Katherine Amato; Hongyan Chai; Jiadi Wen; Peining Li
Journal:  Mol Genet Genomic Med       Date:  2020-05-08       Impact factor: 2.183

3.  A Retrospective Analysis of 10-Year Data Assessed the Diagnostic Accuracy and Efficacy of Cytogenomic Abnormalities in Current Prenatal and Pediatric Settings.

Authors:  Hongyan Chai; Autumn DiAdamo; Brittany Grommisch; Fang Xu; Qinghua Zhou; Jiadi Wen; Maurice Mahoney; Allen Bale; James McGrath; Michele Spencer-Manzon; Peining Li; Hui Zhang
Journal:  Front Genet       Date:  2019-11-20       Impact factor: 4.599

4.  Noninvasive prenatal detection of fetal sex chromosome abnormalities using the semiconductor sequencing platform (SSP) in Southern China.

Authors:  Jiexia Yang; Yaping Hou; Fangfang Guo; Haishan Peng; Dongmei Wang; Yi Li; Haoxin Oy; Yixia Wang; Jian Lu; Aihua Yin
Journal:  J Assist Reprod Genet       Date:  2021-02-10       Impact factor: 3.412

5.  Clinical Application of Noninvasive Prenatal Testing for Sex Chromosome Aneuploidies in Central China.

Authors:  Ganye Zhao; Peng Dai; Conghui Wang; Lina Liu; Xuechao Zhao; Xiangdong Kong
Journal:  Front Med (Lausanne)       Date:  2022-01-26

6.  Positive predictive value of noninvasive prenatal testing for sex chromosome abnormalities.

Authors:  Nan Guo; Meiying Cai; Min Lin; Huili Xue; Hailong Huang; Liangpu Xu
Journal:  Mol Biol Rep       Date:  2022-08-12       Impact factor: 2.742

7.  A case of prenatal diagnosis of 18p deletion syndrome following noninvasive prenatal testing.

Authors:  Ganye Zhao; Peng Dai; Shanshan Gao; Xuechao Zhao; Conghui Wang; Lina Liu; Xiangdong Kong
Journal:  Mol Cytogenet       Date:  2019-12-21       Impact factor: 2.009

8.  Cell-Free DNA Screening for Sex Chromosome Abnormalities and Pregnancy Outcomes, 2018-2020: A Retrospective Analysis.

Authors:  Yanmei Lu; Shihao Zhou; Siyuan Linpeng; Siyi Ding; Shihong Li; Yujiao Li; Liangcheng Shi; Jun He; Yalan Liu
Journal:  J Pers Med       Date:  2022-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.